Protecting pets from fleas, ticks, and other external parasites is a familiar responsibility for dog and cat owners. Regular preventive care can reduce parasite infestations, protect animal welfare, and limit household problems. Yet selecting the correct treatment and remembering when to use it are two separate challenges.
MyPipette is a French company that approaches these concerns through an online pet-care service. Founded in 2021 by Richard Schwemmer, the business distributes the Evitic Combo range of veterinary antiparasitic treatments for dogs, cats, and ferrets. Its purchasing model lets customers order individual treatments or set up recurring deliveries.
Rather than manufacturing its own veterinary medicine, MyPipette works with products made by pharmaceutical manufacturer Chanelle Pharmaceuticals in Ireland.
This article examines MyPipette’s background, leadership, treatment range, purchasing process, safety considerations, and place in the growing market for convenient pet-care services.
What Is MyPipette?
MyPipette is a French online pet-care business that distributes veterinary medicines to treat external parasite infestations. Its product range centers on Evitic Combo, a collection of topical treatments intended for different animal species and weight categories.
The company’s central proposition is convenience. Customers provide pet information, including age and weight, to identify a suitable product category. They can then select an individual purchase or a recurring order, subject to availability.
This approach brings together two established elements of pet care: veterinary parasite treatment and online product delivery. MyPipette operates as a distributor, not a veterinary clinic or the manufacturer of Evitic Combo.
Its significance lies in how it organizes an existing veterinary product around a purchasing system that makes regular parasite protection easier to manage.
The Origins and Background of MyPipette
Richard Schwemmer established MyPipette in 2021. According to the company’s published background, he drew on his experience in commercial distribution and the pharmaceutical sector to create it.
The business is based in Strasbourg, a French city in the Alsace region near the German border. Its public company information identifies Strasbourg as both its registered location and the site from which Evitic Combo products are dispatched.
The service was developed to address a practical concern: pet owners must often administer parasite treatments at set intervals, but purchasing and tracking those treatments can be repetitive.
MyPipette’s model simplifies the purchasing side of that responsibility through online ordering and optional recurring deliveries.
The company’s published history establishes its founding year, founder, location, and product focus. These details provide a more reliable understanding of its development than unsupported claims about its revenue, customer numbers, or market position.
Richard Schwemmer and the Company’s Leadership
Richard Schwemmer founded and leads MyPipette. The company’s public profile credits him with about 30 years of commercial experience, including work in cosmetics, pharmaceuticals, and animal antiparasitic products.
Its published background describes seven years in mail-order sales, 23 years serving the cosmetics and pharmaceutical industries, and 12 years devoted more specifically to antiparasitic products across European and international markets. These periods describe areas of professional experience and should not necessarily be treated as separate, non-overlapping careers.
Schwemmer’s connection to the business is especially relevant because MyPipette combines veterinary products with direct-to-consumer distribution.
Both elements require different forms of expertise. Pharmaceutical products depend on proper manufacturing, authorization, labeling, and safety information, while online retailing requires reliable customer service, fulfillment, and clear purchasing terms.
The company’s public materials identify Schwemmer as the founder and leader but do not provide a broader personal or family biography.
The Pharmaceutical Manufacturing Relationship
A defining characteristic of MyPipette is its relationship with the manufacturer of the products it distributes.
The Evitic Combo treatments sold through the company are manufactured by Chanelle Pharmaceuticals in Galway, Ireland. MyPipette distributes from France, separating pharmaceutical production from the commercial service customers use.
This distinction matters because manufacturers and distributors have different responsibilities. The manufacturer produces the veterinary medicine, while the distributor presents the products, processes orders, and arranges delivery.
Consumers should therefore distinguish the MyPipette company from the Evitic Combo medicine itself.
The relevant veterinary medicine documentation, not subscription arrangements or advertising descriptions, determines product characteristics, approved uses, contraindications, and treatment instructions.
This division of responsibilities is also important when evaluating product safety. A convenient ordering service cannot replace the instructions accompanying an authorized veterinary medicine.
How MyPipette Works
The MyPipette ordering system begins with information about the animal requiring treatment. Customers are asked to provide details such as the pet’s name, age, sex, and weight.
These details are used to guide product selection. Weight matters because the Evitic Combo range includes separate presentations for dogs of different sizes.
After selecting the appropriate product, customers can choose between a single purchase and recurring deliveries. The business advertises delivery directly to the customer’s letterbox, using postal services in metropolitan France.
MyPipette also offers a compact delivery package designed to fit individual pipettes without unnecessary bulk.
The system’s practical purpose is straightforward: it brings treatment selection, purchasing, and planned replenishment into one online process.
Nevertheless, automated product suggestions are not a substitute for veterinary advice. An animal’s medical history, current health, previous reactions, and other treatments may influence which parasite-control product is appropriate.
MyPipette Products for Dogs, Cats, and Ferrets
MyPipette’s published catalog includes several Evitic Combo presentations intended for particular animals and weight groups.
For dogs, the listed categories cover animals weighing 2–10 kg, 10–20 kg, 20–40 kg, and over 40 kg. The catalog also includes a presentation intended for cats and ferrets.
The company’s online selection process lists minimum age and weight requirements: dogs older than eight weeks and weighing more than 2 kg, and cats older than eight weeks and weighing more than 1 kg.
These criteria do not apply across species. Owners must always check the instructions for the specific product and animal.
Evitic Combo is designed to treat fleas and certain other external parasites, with authorized indications that vary by target species.
Parasite protection cannot be evaluated solely by the animal’s weight. Different formulations may have distinct warnings, application instructions, and treatment intervals.
Understanding the Active Ingredients
The Evitic Combo formulations described by MyPipette contain two principal active ingredients: fipronil and (S)-methoprene.
Fipronil is an insecticidal and acaricidal substance used in veterinary parasite treatments. It acts against susceptible external parasites, including fleas and certain ticks.
(S)-methoprene is an insect growth regulator. It disrupts flea development, including the egg and larval stages.
The combination targets different stages of the flea life cycle, making the treatment effective for controlling infestations rather than merely reacting to visible adult fleas.
The exact duration of protection depends on the formulation, animal species, and parasite concerned. Owners should consult the product leaflet rather than assume every effect lasts the same number of weeks.
Neither ingredient makes a medicine universally suitable for all pets. Correct species identification, appropriate dosing, and careful administration remain essential.
Responsible Treatment and Pet Safety
Parasite-control medicine requires careful handling even when it can be purchased online.
MyPipette describes Evitic Combo as a spot-on treatment, meaning the liquid is applied directly to the animal’s skin rather than administered orally.
The company’s instructions describe parting the fur near the base of the neck, between the shoulder blades, so that the contents reach the skin.
Customers should follow the leaflet that accompanies their product, including instructions on treatment frequency, bathing, handling, and preventing the animal from licking the application site.
The company’s safety information explicitly states that Evitic Combo must not be used on rabbits.
Products intended for dogs and cats must never be assumed to be interchangeable. French veterinary authorities have also warned that certain dog antiparasitic medicines containing permethrin can cause severe poisoning in cats. This is a general pet-safety warning, not a claim that Evitic Combo contains permethrin.
If you’re uncertain about an animal’s suitability for treatment, consult a veterinarian or pharmacist before administering it.
Subscription Services and Customer Convenience
The recurring-delivery option is one of MyPipette’s most distinctive commercial features.
Customers can arrange monthly purchases instead of placing a new order each time another treatment is needed. The company aims to help owners maintain a more organized parasite-care routine.
Its published sales conditions describe recurring orders that renew monthly.
Customers can also request a temporary suspension of recurring orders for 1 to 6 months, subject to the company’s conditions.
Cancellation requires attention to the contract. The published terms specify a 15-day notice period before the renewal date for ordinary cancellation at expiry, with separate provisions covering certain price increases.
These details matter because a recurring purchase creates an ongoing payment arrangement, not just an automatic reminder.
Pet owners should review their animal’s treatment schedule and the applicable veterinary instructions independently of delivery frequency.
A monthly shipment does not establish that monthly application is medically appropriate in every circumstance.
Transparency, Availability, and Consumer Trust
Trust in an online veterinary-products retailer depends on more than a convenient website.
Customers need clear information about the company, its products, treatment instructions, ordering conditions, and ways to resolve problems.
MyPipette publishes its corporate identity and French registration details, names its leadership, identifies the Evitic Combo manufacturer, and provides written commercial terms.
Its website also contains important product warnings and information about recurring purchases.
One practical limitation is stock availability. As of October 12, 2026, the official website showed out-of-stock notices across its listed cat and dog treatment categories, along with a message indicating replenishment was underway.
This website status does not indicate when individual products will return or whether it will affect all future deliveries.
Customers should confirm current stock and fulfillment arrangements before ordering, especially when an animal needs parasite protection within a specific treatment window.
Transparent availability information is particularly valuable for products connected to ongoing animal health needs.
MyPipette and the Future of Pet Care
MyPipette illustrates a broader commercial approach in which routine pet-care purchases are organized through online services and scheduled replenishment.
Its model is built around established veterinary medicines rather than a newly invented treatment technology.
The main service innovation is simplifying access through a digital ordering process, weight-based product categories, and a recurring-purchase option.
Whether such a model is useful for a particular household depends on factors including veterinary suitability, product availability, pricing, and flexibility of delivery.
MyPipette should also be distinguished from My Pipette Creator, a separate laboratory software application associated with Thermo Fisher Scientific. Despite the similar names, the laboratory platform is designed to program compatible electronic pipettes and is unrelated to MyPipette’s pet-care business.
MyPipette’s long-term development will depend on its operations, customer service, and ability to maintain reliable access to appropriate veterinary products. Its published information does not establish a confirmed future expansion plan.
Conclusion
MyPipette is a French pet-care business founded in 2021 by Richard Schwemmer, built around distributing Evitic Combo veterinary antiparasitic treatments.
Its approach combines an established range of externally applied medicines with online product selection, home delivery, and optional recurring purchases. Chanelle Pharmaceuticals manufactures in Ireland, while the distribution business operates from Strasbourg.
The company provides a useful example of how routine pet-care purchasing can be organized through a digital service. At the same time, treatment selection and safe administration remain veterinary matters that require careful attention to individual animals.
Prospective customers benefit more from understanding the product range, subscription conditions, safety warnings, and current availability than from convenience claims alone.
(FAQs)
1. What is MyPipette?
MyPipette is a French online business that distributes Evitic Combo veterinary antiparasitic treatments for dogs, cats, and ferrets.
2. Who founded MyPipette?
Richard Schwemmer founded the company in 2021 and is identified as its president.
3. Where is MyPipette based?
MyPipette is based in Strasbourg, France, and its published terms describe delivery services within metropolitan France.
4. Does MyPipette manufacture its own treatments?
No. The company identifies Chanelle Pharmaceuticals in Galway, Ireland, as the manufacturer of the Evitic Combo range it distributes.
5. What parasites does Evitic Combo treat?
Its authorized uses include fleas and, depending on the animal and formulation, certain ticks and biting lice. Owners should consult the specific product leaflet.
6. Does MyPipette offer a subscription?
Yes. The company describes a recurring monthly purchasing arrangement alongside individual orders, subject to its commercial conditions.
7. Can Evitic Combo be used on rabbits?
No. MyPipette’s published product safety information specifically warns against using Evitic Combo on rabbits.
8. Are MyPipette products currently available?
On October 12, 2026, the company’s website displayed out-of-stock notices for its listed treatment categories. Availability can change, so customers should check the latest status before ordering.
